ONC206
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ONC206, covering 2025-12-18 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors [Phase 1]